Type IA topoisomerase inhibition by clamp closure

FASEB J. 2013 Aug;27(8):3030-8. doi: 10.1096/fj.12-226118. Epub 2013 Apr 23.

Abstract

Bacterial DNA topoisomerase I (topoI) catalyzes relaxation of negatively supercoiled DNA. The enzyme alters DNA topology through protein-operated DNA gate, switching between open and closed conformations during its reaction. We describe the mechanism of inhibition of Mycobacterium smegmatis and Mycobacterium tuberculosis topoI by monoclonal antibodies (mAbs) that bind with high affinity and inhibit at 10-50 nM concentration. Unlike other inhibitors of topoisomerases, the mAbs inhibited several steps of relaxation reaction, namely DNA binding, cleavage, strand passage, and enzyme-DNA dissociation. The enhanced religation of the cleaved DNA in presence of the mAb indicated closing of the enzyme DNA gate. The formation of enzyme-DNA heterocatenane in the presence of the mAbs as a result of closing the gate could be inferred by the salt resistance of the complex, visualized by atomic force microscopy and confirmed by fluorescence measurements. Locking the enzyme-DNA complex as a closed clamp restricted the movements of the DNA gate, affecting all of the major steps of the relaxation reaction. Enzyme trapped on DNA in closed clamp conformation formed roadblock for the elongating DNA polymerase. The unusual multistep inhibition of mycobacterial topoisomerases may facilitate lead molecule development, and the mAbs would also serve as valuable tools to probe the enzyme mechanism.

Keywords: DNA cleavage-religation; enzyme-DNA heterocatenane; monoclonal antibody; mycobacteria.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / metabolism
  • Antibodies, Monoclonal / pharmacology*
  • Bacterial Proteins / chemistry
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism*
  • Biocatalysis / drug effects
  • DNA / chemistry
  • DNA / genetics
  • DNA / metabolism
  • DNA Cleavage / drug effects
  • DNA Topoisomerases, Type I / genetics
  • DNA Topoisomerases, Type I / immunology
  • DNA Topoisomerases, Type I / metabolism*
  • Models, Biological
  • Models, Molecular
  • Mutation
  • Mycobacterium smegmatis / enzymology
  • Mycobacterium tuberculosis / enzymology
  • Nucleic Acid Conformation
  • Oligonucleotides / chemistry
  • Oligonucleotides / genetics
  • Oligonucleotides / metabolism
  • Protein Binding / drug effects
  • Protein Structure, Tertiary
  • Spectrometry, Fluorescence
  • Topoisomerase Inhibitors / chemistry
  • Topoisomerase Inhibitors / immunology
  • Topoisomerase Inhibitors / pharmacology*

Substances

  • Antibodies, Monoclonal
  • Bacterial Proteins
  • Oligonucleotides
  • Topoisomerase Inhibitors
  • DNA
  • DNA Topoisomerases, Type I